Miocardiopatía arritmogénica de ventrículo izquierdo
Ya tenemos una nueva infografía creada por el Dr. Edgardo Alania para su impresionante sección.
Related Articles
Effective risk stratification in pulmonary embolism: evaluating current tools and identifying research gaps
Currently, most international guidelines advocate for risk stratification of acute pulmonary embolism (PE) as a framework to guide treatment decisions. Key prognostic factors for patients…
La Imagen + Bella 2024 – Galería
Ganadores y galería de imágenes participantes de la VI Edición del Concurso “La Imagen + Bella” de 2024.
Effective risk stratification in pulmonary embolism: evaluating current tools and identifying research gaps
Currently, most international guidelines advocate for risk stratification of acute pulmonary embolism (PE) as a framework to guide treatment decisions. Key prognostic factors for patients…
Flecainide for the Treatment of Andersen-Tawil Syndrome:
AbstractBackgroundAndersen-Tawil syndrome type 1 (ATS1) is a rare arrhythmogenic disorder resulting from loss-of-function mutations in KCNJ2. Although the use of flecainide has been proposed to…
Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure:
AbstractImplantable cardioverter-defibrillators (ICDs) protect patients from sudden cardiac death (SCD). Landmark trials demonstrating their efficacy for primary prevention in patients with heart f…
Physiological pacing: mechanisms, clinical indications, and perspectives
Abstract. Normal cardiac function depends on a highly efficient cardiac conduction system. Conduction system disease impairs cardiac function, which can re
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score
AbstractBackground and Aims. The prediction of the first major arrhythmic event (MAE) is still an unmet need in the recently defined scenario of non-dilate
Miocardiopatía arritmogénica de ventrículo derecho (2)
Seguimos con la espectacular serie de infografías del Dr. Edgardo Alania para la SEIC.
Managing glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in clinical practice
The obesity epidemic has significantly heightened the impact of cardiometabolic risk factors on the global burden of cardiovascular and kidney diseases. Glucagon-like peptide-1 receptor agonists…
Transthyretin Amyloid Cardiomyopathy—2025 Update: Current Diagnostic Approaches and Emerging Therapeutic Options
Transthyretin-related (ATTR) amyloidosis is a progressive, multisystem disease caused by the extracellular deposition of misfolded transthyretin (TTR) monomers as insoluble amyloid fibrils. Clinical manifestations vary…